DFTX
As of 2026-11-06, Definium Therapeutics, Inc. (DFTX) has a market capitalization of $3.60 B, making it the #1649 most valuable US-listed company.
| Date | Market cap |
|---|---|
| 2026-11-06 | $3.60 B |
| 2026-11-05 | $3.35 B |
| 2026-11-04 | $3.57 B |
| 2026-11-03 | $3.69 B |
| 2026-11-02 | $3.56 B |
| 2026-11-01 | $3.96 B |
| 2026-10-31 | $3.96 B |
| 2026-10-30 | $3.96 B |
| 2026-10-29 | $4.14 B |
| 2026-10-28 | $4.16 B |
| 2026-10-27 | $4.04 B |
| 2026-10-26 | $3.88 B |
As of 2026-11-06, Definium Therapeutics, Inc. (DFTX) has a market capitalization of $3.60 B, making it the #1649 most valuable US-listed company.
Definium Therapeutics, Inc. is the #1649 largest US-listed company by market capitalization.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| 2026-10-25 | $3.89 B |
| 2026-10-24 | $3.89 B |
| 2026-10-23 | $3.89 B |
| 2026-10-22 | $3.93 B |
| 2026-10-21 | $3.88 B |
| 2026-10-20 | $3.83 B |
| 2026-10-19 | $3.60 B |
| 2026-10-18 | $3.50 B |
| 2026-10-17 | $3.50 B |
| 2026-10-16 | $3.50 B |
| 2026-10-15 | $3.74 B |
| 2026-10-14 | $3.73 B |
| 2026-10-13 | $3.75 B |
| 2026-10-12 | $3.84 B |
| 2026-10-11 | $4.02 B |
| 2026-10-10 | $4.02 B |
| 2026-10-09 | $4.02 B |
| 2026-10-08 | $3.73 B |
Readings accumulate daily as market data refreshes, combining SEC-reported share counts with live prices.